Niraparib: First Global Approval

This article summarizes the milestones in the development of niraparib leading to its first global approval for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer.
Source: Drugs - Category: Drugs & Pharmacology Source Type: research